Latest Posts
About This Stock
More About This Stock
Read
Read
Moderna ETFs To Gain On New Positive COVID-19 Vaccine Data
Article By:
Zacks Investment Research
Friday, August 28, 2020 6:31 PM EDT
The competition to come up with a coronavirus vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.
Moderna - A Step Closer To Coronavirus Vaccine: ETFs To Gain
Article By:
Zacks Investment Research
Sunday, June 14, 2020 3:44 PM EDT
The first company to start human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has informed that it is on schedule to initiate the final-stage clinical trial by July.